Your browser doesn't support javascript.
loading
The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosis.
Conforti, Franco; Davies, Elizabeth R; Calderwood, Claire J; Thatcher, Thomas H; Jones, Mark G; Smart, David E; Mahajan, Sumeet; Alzetani, Aiman; Havelock, Tom; Maher, Toby M; Molyneaux, Philip L; Thorley, Andrew J; Tetley, Teresa D; Warner, Jane A; Packham, Graham; Ganesan, A; Skipp, Paul J; Marshall, Benjamin J; Richeldi, Luca; Sime, Patricia J; O'Reilly, Katherine M A; Davies, Donna E.
Afiliação
  • Conforti F; The Brooke Laboratory, Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, University Hospital Southampton, Southampton, UK.
  • Davies ER; NIHR Respiratory Biomedical Research Unit, University Hospital Southampton, Southampton, UK.
  • Calderwood CJ; The Brooke Laboratory, Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, University Hospital Southampton, Southampton, UK.
  • Thatcher TH; NIHR Respiratory Biomedical Research Unit, University Hospital Southampton, Southampton, UK.
  • Jones MG; The Brooke Laboratory, Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, University Hospital Southampton, Southampton, UK.
  • Smart DE; Department of Medicine/Pulmonary & Critical Care, University of Rochester, Rochester, NY, USA.
  • Mahajan S; The Brooke Laboratory, Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, University Hospital Southampton, Southampton, UK.
  • Alzetani A; NIHR Respiratory Biomedical Research Unit, University Hospital Southampton, Southampton, UK.
  • Havelock T; The Brooke Laboratory, Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, University Hospital Southampton, Southampton, UK.
  • Maher TM; NIHR Respiratory Biomedical Research Unit, University Hospital Southampton, Southampton, UK.
  • Molyneaux PL; Institute for Life Sciences, University of Southampton, Highfield, UK.
  • Thorley AJ; University Hospital Southampton, Southampton, UK.
  • Tetley TD; NIHR Respiratory Biomedical Research Unit, University Hospital Southampton, Southampton, UK.
  • Warner JA; University Hospital Southampton, Southampton, UK.
  • Packham G; NIHR Respiratory Biomedical Research Unit, Royal Brompton Hospital, London, UK.
  • Ganesan A; National Heart & Lung Institute, Faculty of Medicine, Imperial College, London, UK.
  • Skipp PJ; NIHR Respiratory Biomedical Research Unit, Royal Brompton Hospital, London, UK.
  • Marshall BJ; National Heart & Lung Institute, Faculty of Medicine, Imperial College, London, UK.
  • Richeldi L; National Heart & Lung Institute, Faculty of Medicine, Imperial College, London, UK.
  • Sime PJ; National Heart & Lung Institute, Faculty of Medicine, Imperial College, London, UK.
  • O'Reilly KMA; The Brooke Laboratory, Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, University Hospital Southampton, Southampton, UK.
  • Davies DE; NIHR Respiratory Biomedical Research Unit, University Hospital Southampton, Southampton, UK.
Oncotarget ; 8(30): 48737-48754, 2017 Jul 25.
Article em En | MEDLINE | ID: mdl-28467787

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Depsipeptídeos / Fibrose Pulmonar Idiopática / Inibidores de Histona Desacetilases Limite: Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Depsipeptídeos / Fibrose Pulmonar Idiopática / Inibidores de Histona Desacetilases Limite: Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article